Ultrasound Versus Fluoroscopic Guided Sacroiliac Joint Injection In Patients With Chronic Sacroiliac Joint Pain
1 other identifier
interventional
40
1 country
1
Brief Summary
Sacroiliac joint injection in sacroiliitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2020
CompletedFirst Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
June 25, 2020
CompletedJune 25, 2020
June 1, 2020
4 months
May 19, 2020
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Numeric Rating Scale (NRS) pain scores
It measures pain intensity (0 no pain - 10 worst pain imaginable)
3 months
Oswestry disability index score
It evaluates the physical function (0% minimal disability - 100% bed - bound patient)
1 month
Secondary Outcomes (3)
Analgesic requirement
1 month
Patient satisfaction ( global perceived effect on a 7-point scale (GPE) )
3 months
Procedure time
Procedure
Study Arms (2)
Ultrasound(US)
EXPERIMENTALSacroiliac joint injection using ultrasound
Fluoroscopy(FL)
EXPERIMENTALSacroiliac joint injection using fluoroscopy
Interventions
Injection of sacroiliac joint with local anesthetic and steroid
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of sacroiliitis.
- At least 3 positive physical examination maneuvers \[FABER (flexion, abduction, and external rotation), POSH (posterior shear), REAB (resisted abduction), Fortin's finger test\],
- Moderate to severe pain (NRS pain score ≥ 3/10) refractory to oral anti-inflammatory.
- Age from 18ys to 60ys.
You may not qualify if:
- Ages less than 18 or more than 85 years.
- Body Mass Index (BMI) above 35 kg/m2.
- A diagnosis of severe anxiety or depression and other psychological disorders.
- Allergy to local anesthetics or steroids and pregnancy.
- Multiple comorbidities (renal , hepatic, cardiac).
- Coagulation disorder as bleeding tendency and platelet dysfunction.
- Contraindication for prone position or radiological exposure.
- Patient refuse .
- Pain suggestive of bilateral sacroiliac joint involvement (it would have been difficult to assess pain and disability secondary to each SIJ).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
ASSIUT University Hospitals
Asyut, 1225, Egypt
Related Publications (1)
Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res. 2013 Jan;41(Database issue):D36-42. doi: 10.1093/nar/gks1195. Epub 2012 Nov 27.
PMID: 23193287RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Hany Ka Mickhael, Ass. pr.
Minia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
May 19, 2020
First Posted
June 25, 2020
Study Start
October 15, 2019
Primary Completion
February 15, 2020
Study Completion
March 15, 2020
Last Updated
June 25, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share